<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23758" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Iontophoresis Analgesic Medications</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sheikh</surname>
            <given-names>Nafiz K.</given-names>
          </name>
          <aff>Medical College of Georgia at Augusta University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dua</surname>
            <given-names>Anterpreet</given-names>
          </name>
          <aff>Augusta University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nafiz Sheikh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anterpreet Dua declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23758.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Analgesic iontophoresis is the administration of analgesic medications via iontophoresis used in the management and treatment of pain. The technique may employ multiple classes of drugs. This activity outlines the indications, action, and contraindications for iontophoresis as a valuable agent in the management of painful conditions. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team and patients in the management of patients with acute or chronic pain and related conditions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the mechanism of action and administration of iontophoretic analgesia.</p></list-item><list-item><p>Describe the adverse effects and contraindications of iontophoretic analgesia.</p></list-item><list-item><p>Outline appropriate monitoring and toxicity of iontophoretic analgesia.</p></list-item><list-item><p>Review interprofessional team strategies for improving care coordination and communication to advance iontophoretic analgesia and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23758&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23758">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23758.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Iontophoresis is a method of transdermal drug delivery wherein a clinician uses an electric current to promote localized, superficial permeation of a therapeutic agent through the skin. Among the earliest applications of electrical current for medical therapy was by Pivati in 1740 to treat arthritis.<xref ref-type="bibr" rid="article-23758.r1">[1]</xref>&#x000a0;More notable advances were made during the 1800s by pioneering scientists such as Benjamin Ward Richardson, William James Morton, and Frtiz Frankenh&#x000e4;user - the latter of whom coined the phrase &#x0201c;iontophoresis&#x0201d; in favor of &#x0201c;cataphoresis&#x0201d; which had been used more commonly prior to the 20th century.<xref ref-type="bibr" rid="article-23758.r2">[2]</xref>&#x000a0;More recently, iontophoresis has been referred to as &#x0201c;electrically-assisted transdermal drug delivery&#x0201d; in some clinical contexts as well.</p>
        <p>Nomenclature notwithstanding, the indications for iontophoresis are numerous and may involve local, regional, or systemic delivery. Localized delivery of therapeutic agents includes local anesthetics (e.g., lidocaine) and&#x000a0;fentanyl for analgesia, retinoids, and corticosteroids to treat scarring from acne, and antiperspirants for palmar and plantar hyperhidrosis.<xref ref-type="bibr" rid="article-23758.r2">[2]</xref><xref ref-type="bibr" rid="article-23758.r3">[3]</xref><xref ref-type="bibr" rid="article-23758.r4">[4]</xref><xref ref-type="bibr" rid="article-23758.r5">[5]</xref>&#x000a0;Regional applications of iontophoresis include the delivery of anti-inflammatory agents into subcutaneous tissue and joint spaces to relieve tendonitis, arthritis, or transient muscle soreness. Lastly and more rarely, systemic delivery of drugs via transdermal iontophoresis include fentanyl for analgesia, antimigraine agents (e.g., triptan drugs) for headache, nicotine for smoking cessation, reversible cholinesterase inhibitors such as rivastigmine&#x000a0;for Alzheimer disease, and even proteins or peptides such as insulin.<xref ref-type="bibr" rid="article-23758.r6">[6]</xref><xref ref-type="bibr" rid="article-23758.r7">[7]</xref><xref ref-type="bibr" rid="article-23758.r8">[8]</xref><xref ref-type="bibr" rid="article-23758.r9">[9]</xref><xref ref-type="bibr" rid="article-23758.r10">[10]</xref><xref ref-type="bibr" rid="article-23758.r11">[11]</xref><xref ref-type="bibr" rid="article-23758.r12">[12]</xref><xref ref-type="bibr" rid="article-23758.r13">[13]</xref></p>
        <p>This activity will explore the indications, mechanisms, and benefits/risks of iontophoresis in the context of analgesic medication delivery and pain relief both locally and systemically.</p>
      </sec>
      <sec id="article-23758.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Transdermal iontophoresis of analgesics involves the use of an electromotive gradient (i.e., voltage) across a positively-charged anode and negatively-charged cathode to induce percutaneous infiltration of a therapeutic agent via active transport for local, regional, or systemic delivery (Figure 1). The primary interface medications must travel through is the stratum corneum (SC) of the skin, approximately 10&#x000a0;to 100 micrometers in thickness.<xref ref-type="bibr" rid="article-23758.r2">[2]</xref> Three primary pathways exist for absorption through the SC: paracellular (between keratinocytes), transcellular (through keratinocytes), and appendageal (through hair follicles, sudoriferous glands, sebaceous glands, etc.) with the latter believed to have the lowest electromotive resistance.<xref ref-type="bibr" rid="article-23758.r2">[2]</xref><xref ref-type="bibr" rid="article-23758.r14">[14]</xref>&#x000a0;The quantification of percutaneous permeation is generally as a chemical flux (flow rate of the molecular or ionic agents over a given surface area). Employing electron-repulsion as a driving force, iontophoresis entails placing positively-ionized (cationic) or neutral medications below the positively-charged electrode (anode). In contrast, negatively-ionized drugs become oriented below the negatively-charged electrode (cathode) (Figure 1). Due to electrostatic repulsion, agents are driven away from their like-charged electrode(s) and through the integumentary interface. Numerous factors affecting medication flux and end-delivery have been elucidated and include the following <xref ref-type="bibr" rid="article-23758.r2">[2]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Electrochemical properties of the analgesic solution (e.g., charge, concentration, molecular size, delivery mechanism, buffer type, and viscosity of analgesic and non-analgesic constituents)</p>
          </list-item>
          <list-item>
            <p>Iontophoretic equipment parameters (current amplitude, type, frequency, and duration)</p>
          </list-item>
          <list-item>
            <p>Patient physiology (skin moisture, local blood flow, temperature)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23758.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Multiple formulations for analgesic agent delivery via iontophoresis exist currently with approval from the Food and Drug Administration. These include various formulations including patient-activated fentanyl 40 mcg solution, lidocaine hydrochloride (HCl) 2% with epinephrine 1&#x000a0;to 100000 solution, lidocaine HCl with epinephrine topical iontophoretic patch (10%/0.1%), and lidocaine HCl 4% solution.</p>
      </sec>
      <sec id="article-23758.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Transdermal iontophoresis is generally considered one of the safest delivery modalities; however, researchers have noted adverse effects in the literature. Due to its penetration of cutaneous media, among the most reported side effects of the procedure include local paresthesia, itching, irritation, erythema, edema, and galvanic urticaria.<xref ref-type="bibr" rid="article-23758.r15">[15]</xref><xref ref-type="bibr" rid="article-23758.r16">[16]</xref><xref ref-type="bibr" rid="article-23758.r17">[17]</xref>&#x000a0;More rarely, however, patients may experience a burning sensation and even superficial skin burns, most often due to improper electrode placement or medication formulation. Factors such as higher current, longer durations of administration, electrode placement over skin defects, use of inadequate or relatively alkaline phase buffers, and use of bare metal or carbon electrodes all increase the risk of skin damage and burns.<xref ref-type="bibr" rid="article-23758.r18">[18]</xref>&#x000a0;Patients and healthcare providers may mitigate the likelihood of cutaneous injuries by avoiding non-uniform electrode compression at the cutaneous surface with an adhesive seal, placing adequately wetted sponges between the electrode and skin, cleaning the application site with alcohol, and avoiding areas of skin lesions or defects with a current, and maintaining an ion flux of below 0.5 mA/cm^2.<xref ref-type="bibr" rid="article-23758.r15">[15]</xref><xref ref-type="bibr" rid="article-23758.r19">[19]</xref><xref ref-type="bibr" rid="article-23758.r20">[20]</xref></p>
      </sec>
      <sec id="article-23758.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications to iontophoresis include those related to direct electrical stimulation and from the therapeutic agent involved. Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in question should avoid iontophoresis of the offending agent. Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels. Clinicians should avoid the procedure in the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.<xref ref-type="bibr" rid="article-23758.r21">[21]</xref>&#x000a0;There has been no investigation of iontophoresis during pregnancy and, therefore, it either should not be used or used with extreme caution during pregnancy.</p>
      </sec>
      <sec id="article-23758.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Depending on the analgesic agent delivered, the scope and intensity of patient monitoring may vary. As mentioned before, among the most used agents for analgesia in the context of iontophoresis include local anesthetics and fentanyl. For both agents, signs of adverse skin reactions and systemic symptoms indicative of hypersensitivity or toxicity require close monitoring, and the treating clinician should undertake steps to mitigate and reverse symptoms promptly.<xref ref-type="bibr" rid="article-23758.r22">[22]</xref><xref ref-type="bibr" rid="article-23758.r23">[23]</xref><xref ref-type="bibr" rid="article-23758.r24">[24]</xref>&#x000a0;Additional monitoring modalities may include:</p>
        <list list-type="order">
          <list-item>
            <p>Electrocardiography (EKG)</p>
          </list-item>
          <list-item>
            <p>Pulse oximetry</p>
          </list-item>
          <list-item>
            <p>Blood pressure</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23758.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>In addition to localized, cutaneous adverse effects, patients may experience adverse or even toxicity symptoms stemming from offending therapeutic agents as well. In the context of iontophoretic analgesia, the most used medicines are local anesthetics and fentanyl. With the use of local anesthetics (chiefly lidocaine and lidocaine/epinephrine), acute concerns arise for local adverse reactions and local anesthetic systemic toxicity (LAST). Cardiopulmonary symptoms include heart block, cardiac arrhythmia, respiratory insufficiency and arrest, and cardiac arrest. The central nervous system may similarly experience depression with symptoms such as tinnitus, ataxia, akathisia, seizures, altered levels of consciousness, and coma.<xref ref-type="bibr" rid="article-23758.r22">[22]</xref><xref ref-type="bibr" rid="article-23758.r25">[25]</xref>&#x000a0;Management of LAST includes <xref ref-type="bibr" rid="article-23758.r22">[22]</xref><xref ref-type="bibr" rid="article-23758.r26">[26]</xref><xref ref-type="bibr" rid="article-23758.r27">[27]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>Airway management with ventilation, oxygenation</p>
          </list-item>
          <list-item>
            <p>Cardiovascular support with epinephrine and antiarrhythmic agents</p>
          </list-item>
          <list-item>
            <p>Prophylaxis and suppression of seizures with benzodiazepines and succinylcholine</p>
          </list-item>
          <list-item>
            <p>Local anesthetic reduction from intravascular space with lipid-emulsion and bypass</p>
          </list-item>
        </list>
        <p>With the use of fentanyl, patients may experience cardiopulmonary and CNS depressive symptoms as described before with LAST, however, due to its narrow therapeutic window and often systemic delivery, toxicity symptoms of more acute concern.<xref ref-type="bibr" rid="article-23758.r28">[28]</xref>&#x000a0;Although there are no reports of cases of an iontophoretic fentanyl overdose, any compromise to the delivery mechanism may result in the administration of supratherapeutic doses without patient awareness.<xref ref-type="bibr" rid="article-23758.r15">[15]</xref>&#x000a0;In cases of a fentanyl overdose, medically appropriate interventions are similar to those of other opioid overdoses, including <xref ref-type="bibr" rid="article-23758.r28">[28]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>Primary survey with airway, breathing, and circulatory support</p>
          </list-item>
          <list-item>
            <p>Administration of intravenous (IV), intramuscular (IM), subcutaneous (SQ), or intranasal (NAS) administration of naloxone</p>
          </list-item>
          <list-item>
            <p>If indicated, some special circumstances may require complementing the above regimen with activated charcoal, bowel irrigation, and buprenorphine.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23758.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Analgesic iontophoresis has numerous applications and offers benefits, including its relative non-invasiveness and bypass of the first-pass metabolism. However, its use in pain relief has been precluded by the more cost-effective nature of injection and transdermal skin patches in addition to safety concerns of unintended overdose.<xref ref-type="bibr" rid="article-23758.r15">[15]</xref>&#x000a0;Nonetheless, newer advances may make technology more promising for analgesia in the future. Practitioners prescribing or administering iontophoretic therapies in addition to patients should be acutely aware of indications, realistic therapy goals, and the benefits and risks that accompany the intervention, and consult with a pharmacist to ensure appropriate dosing and the absence of drug interactions. Patients and practitioners should moreover be adequately informed of all clinically germane aspects of the procedure to ensure the correct use and proper administration. Lastly, all of the interprofessional team involved (e.g., physicians, nurses, therapists, pharmacists, patients) should be aware of adverse symptoms and potential signs of toxicity and hypersensitivity and adequately monitor for these signs, as discussed before, to mitigate any adverse outcomes promptly. Pharmacists review medications for indications, dosage, and interactions. Nurses monitor patients, provide education, and report responses and issues to the team. [Level 5]</p>
      </sec>
      <sec id="article-23758.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23758&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23758">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23758/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23758">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23758.s11">
        <title>References</title>
        <ref id="article-23758.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anliker</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Kreyden</surname>
                <given-names>OP</given-names>
              </name>
            </person-group>
            <article-title>Tap water iontophoresis.</article-title>
            <source>Curr Probl Dermatol</source>
            <year>2002</year>
            <volume>30</volume>
            <fpage>48</fpage>
            <page-range>48-56</page-range>
            <pub-id pub-id-type="pmid">12471698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rawat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vengurlekar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rakesh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srikarti</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Transdermal delivery by iontophoresis.</article-title>
            <source>Indian J Pharm Sci</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-10</page-range>
            <pub-id pub-id-type="pmid">20390073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maloney</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Local anesthesia obtained via iontophoresis as an aid to shave biopsy.</article-title>
            <source>Arch Dermatol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>331</fpage>
            <page-range>331-2</page-range>
            <pub-id pub-id-type="pmid">1550364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macheiner</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bieglmayer</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin.</article-title>
            <source>Int J Dermatol</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-7</page-range>
            <pub-id pub-id-type="pmid">7896490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sloan</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Soltani</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Iontophoresis in dermatology. A review.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1986</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>4 Pt 1</issue>
            <fpage>671</fpage>
            <page-range>671-84</page-range>
            <pub-id pub-id-type="pmid">3534013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegel</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dub&#x000e9;</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Kaldeway</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sebree</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.</article-title>
            <source>Pharm Res</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>10</issue>
            <fpage>1919</fpage>
            <page-range>1919-26</page-range>
            <pub-id pub-id-type="pmid">17577644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierce</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marbury</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sebree</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Zelrix: a novel transdermal formulation of sumatriptan.</article-title>
            <source>Headache</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>817</fpage>
            <page-range>817-25</page-range>
            <pub-id pub-id-type="pmid">19438727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chelly</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Grass</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Houseman</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Minkowitz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pue</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial.</article-title>
            <source>Anesth Analg</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>98</volume>
            <issue>2</issue>
            <fpage>427</fpage>
            <page-range>427-433</page-range>
            <pub-id pub-id-type="pmid">14742382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Escobar-Ch&#x000e1;vez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Merino</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Cervantes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Cruz</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Quintanar-Guerrero</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ganem-Quintanar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.</article-title>
            <source>Curr Drug Discov Technol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-85</page-range>
            <pub-id pub-id-type="pmid">19496753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaskari</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vuorio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kontturi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Urtti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manzanares</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hirvonen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Controlled transdermal iontophoresis by ion-exchange fiber.</article-title>
            <source>J Control Release</source>
            <year>2000</year>
            <month>Jul</month>
            <day>03</day>
            <volume>67</volume>
            <issue>2-3</issue>
            <fpage>179</fpage>
            <page-range>179-90</page-range>
            <pub-id pub-id-type="pmid">10825552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chien</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Lelawongs</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Direct current iontophoretic transdermal delivery of peptide and protein drugs.</article-title>
            <source>J Pharm Sci</source>
            <year>1989</year>
            <month>May</month>
            <volume>78</volume>
            <issue>5</issue>
            <fpage>376</fpage>
            <page-range>376-83</page-range>
            <pub-id pub-id-type="pmid">2664126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rastogi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis.</article-title>
            <source>Pharm Res</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-33</page-range>
            <pub-id pub-id-type="pmid">12033375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin.</article-title>
            <source>J Control Release</source>
            <year>2009</year>
            <month>Oct</month>
            <day>01</day>
            <volume>139</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-72</page-range>
            <pub-id pub-id-type="pmid">19481577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riviere</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Heit</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Electrically-assisted transdermal drug delivery.</article-title>
            <source>Pharm Res</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>687</fpage>
            <page-range>687-97</page-range>
            <pub-id pub-id-type="pmid">9210183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roustit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blaise</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cracowski</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Trials and tribulations of skin iontophoresis in therapeutics.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-71</page-range>
            <pub-id pub-id-type="pmid">23590287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Van Steeg</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Putter</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Van Der Spek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pavel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Danhof</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bouwstra</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous side-effects of transdermal iontophoresis with and without surfactant pretreatment: a single-blinded, randomized controlled trial.</article-title>
            <source>Br J Dermatol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>153</volume>
            <issue>2</issue>
            <fpage>404</fpage>
            <page-range>404-12</page-range>
            <pub-id pub-id-type="pmid">16086757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meffert</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Galvanic urticaria.</article-title>
            <source>Cutis</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>327</fpage>
            <page-range>327-8</page-range>
            <pub-id pub-id-type="pmid">10388952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <article-title>Lesions and shocks during iontophoresis.</article-title>
            <source>Health Devices</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>123</fpage>
            <page-range>123-5</page-range>
            <pub-id pub-id-type="pmid">9067727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warden</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Electrical safety in iontophoresis.</article-title>
            <source>Rehab Manag</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>20</fpage>
            <page-range>20, 22-3</page-range>
            <pub-id pub-id-type="pmid">17366933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dixit</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bali</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Baboota</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahuja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Iontophoresis - an approach for controlled drug delivery: a review.</article-title>
            <source>Curr Drug Deliv</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">17269912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000f6;lzle</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Tap water iontophoresis].</article-title>
            <source>Hautarzt</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>462</fpage>
            <page-range>462-8</page-range>
            <pub-id pub-id-type="pmid">22660258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r22">
          <label>22</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mahajan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Derian</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Local Anesthetic Toxicity</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>10</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">29763139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r23">
          <label>23</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Schiller</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mechanic</surname>
                <given-names>OJ</given-names>
              </name>
            </person-group>
            <chapter-title>Opioid Overdose</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">29262202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfe</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Spillars</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Local Anesthetic Systemic Toxicity: Reviewing Updates From the American Society of Regional Anesthesia and Pain Medicine Practice Advisory.</article-title>
            <source>J Perianesth Nurs</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>1000</fpage>
            <page-range>1000-1005</page-range>
            <pub-id pub-id-type="pmid">30449428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Essentials of local anesthetic pharmacology.</article-title>
            <source>Anesth Prog</source>
            <year>2006</year>
            <season>Fall</season>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>98</fpage>
            <page-range>98-108; quiz 109-10</page-range>
            <pub-id pub-id-type="pmid">17175824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinberg</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Treatment of local anesthetic systemic toxicity (LAST).</article-title>
            <source>Reg Anesth Pain Med</source>
            <year>2010</year>
            <season>Mar-Apr</season>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>188</fpage>
            <page-range>188-93</page-range>
            <pub-id pub-id-type="pmid">20216036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Picard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Meek</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Lipid emulsion to treat overdose of local anaesthetic: the gift of the glob.</article-title>
            <source>Anaesthesia</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-9</page-range>
            <pub-id pub-id-type="pmid">16430560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23758.r28">
          <label>28</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ramos-Matos</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Bistas</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Lopez-Ojeda</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <chapter-title>Fentanyl</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">29083586</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
